Dystonia Europe, Brussels, Belgium.
European Reference Network for Rare Neurological Diseases, Tübingen, Germany.
Orphanet J Rare Dis. 2022 Mar 21;17(1):130. doi: 10.1186/s13023-022-02270-4.
Patient journey maps are increasingly used as a tool that enables healthcare providers to refine their service provision to best meet patient needs. We developed a cervical dystonia patient journey map (CDPJM) that describes the holistic patient experience from pre-diagnosis through to long-term treatment.
The CDPJM was developed in 2 stages; a patient survey (open questions and multichoice) of 15 patients with CD was conducted to inform the design of the CDPJM, which was then refined and validated by an expert-patient focus group.
Qualitative analysis of the patient survey supported five key stages of the patient journey: symptom onset, diagnosis and therapeutic relationship with healthcare professionals, initiation of care for CD, start of CD treatment, and living with treated CD. Following symptom onset, survey respondents described having multiple visits to their family doctor who prescribed strong pain killers and muscle relaxants and referred their patient to up to 10 different specialists for diagnosis. Over half (53.3%) of respondents had received ≥ 1 misdiagnosis. Respondents reported relief at having a diagnosis but a lack of understanding of the prognosis and treatment options; 46.7% said their neurologist did not spend enough time addressing their concerns. Survey respondents reported using a variety of alternative sources of information, including the internet (86.7%), self-help groups (66.7%) and information leaflets provided by health care professionals (60.0%). While botulinum toxin (BoNT) was consistently discussed as the main treatment option, some neurologists also mentioned physiotherapy, counselling, and other complementary approaches. However, patients were often left to seek complementary services themselves. Patients reported a 'rollercoaster' of relief with BoNT treatment with symptoms (and subsequent impact on daily life) returning towards the end of an injection cycle. "When BoNT works well I can return to an almost normal life … when the injections stop working so well, I have to rest more and avoid going to work and experience life restrictions."
We present the first patient journey map for CD that can be used to guide local service mapping and to compare current provision with what patients say they want and need.
患者旅程图作为一种工具,越来越多地被用于改善医疗服务提供者提供服务的方式,以更好地满足患者的需求。我们开发了一种颈肌张力障碍患者旅程图(CDPJM),描述了从预诊断到长期治疗的整体患者体验。
CDPJM 分两个阶段开发;对 15 名 CD 患者进行了患者调查(开放式问题和多项选择),以告知 CDPJM 的设计,然后由专家-患者焦点小组对其进行改进和验证。
对患者调查的定性分析支持患者旅程的五个关键阶段:症状出现、与医疗保健专业人员的诊断和治疗关系、开始治疗 CD、开始 CD 治疗以及接受治疗的 CD 后生活。症状出现后,调查受访者描述说他们多次去看家庭医生,家庭医生开了强效止痛药和肌肉松弛剂,并将他们的患者转介给多达 10 位不同的专家进行诊断。超过一半(53.3%)的受访者曾接受过≥1 次误诊。受访者表示在确诊后感到宽慰,但对预后和治疗选择缺乏了解;46.7%的人表示他们的神经科医生没有花足够的时间解决他们的担忧。调查受访者报告说,他们使用了各种替代信息来源,包括互联网(86.7%)、自助小组(66.7%)和医疗保健专业人员提供的信息传单(60.0%)。虽然肉毒毒素(BoNT)一直被讨论为主要治疗选择,但一些神经科医生也提到了物理治疗、咨询和其他补充方法。然而,患者往往只能自己寻求补充服务。患者报告说,BoNT 治疗有“过山车”般的缓解效果,症状(以及随后对日常生活的影响)在注射周期结束时会再次出现。“当 BoNT 效果良好时,我可以恢复几乎正常的生活……当注射效果不再那么好时,我必须多休息,避免上班,并体验到生活的限制。”
我们展示了首个 CD 患者旅程图,可用于指导当地服务图,并将当前服务与患者所说的他们想要和需要的服务进行比较。